NMR

Adesis is a contract development and manufacturing organization (CDMO) that partners with pharmaceutical, medical device, and specialty materials companies to develop, scale, and commercialize complex chemistry from early discovery through manufacturing. It operates US facilities in Delaware and a 17-acre site in County Clare, Ireland, and is a subsidiary of Universal Display Corporation (Nasdaq OLED).

analytical chemistrychiral separationcustom peptide synthesisdeuterationdiscovery chemistryflow chemistryGC-MSHPLC-MSprocess chemistryScale upsolid-phase synthesissolution-phase synthesisspecialty manufacturing

Alamanda Polymers specializes in the manufacturing of well-defined polyamino acids for research laboratories doing work in gene therapy, encapsulation, drug delivery, cell adhesion, and surface coating. The company provides metal-free biopolymers including homopolyamino acids and PEGylated polyamino acids, and was formed in 2007.

conjugationcustom synthesisend-group functionalizationGPC coupled to light scatteringmaterials characterizationpolymerization without metal catalysts

BioAscent is a provider of integrated drug discovery services based at the former Organon/MSD R&D site in Newhouse, Scotland, UK. Founded in 2013, its services include assay development, target analysis, compound screening, medicinal and synthetic chemistry, computational chemistry, DMPK, protein science and compound management, with access to in-house diversity and fragment libraries.

assay developmentbiophysicscompound managementcompound screeningcompound storage and logisticscomputational chemistryDMPKhigh throughput screeningin silico discoveryLC-MSliquid handlingmedicinal chemistryprotein productionpurificationstructural biologysurface plasmon resonancesynthetic chemistry

Chem-Master International, Inc. is a research, development, and manufacturing company founded in 1994 that specializes in contract projects, providing custom chemical synthesis, process development, and chemical research services to pharmaceutical companies, biotechnology organizations, drug discovery groups, and academic institutions in the U.S. and Europe.

analytical methods development and validationcGMP synthesischemical researchcontract synthesiscustom synthesisFT-IRGCHPLCLC/MSprocess chemistryprocess developmentroute scouting and selectionScale up

ChiroBlock is a synthetic chemistry and contract research company based in Wolfen, Germany, specializing in custom synthesis of complex, commercially unavailable molecules. Since 1999 it has provided services from first-time synthesis to scalable production (mg to kg), including route scouting, process development, and reliable supply of high-purity compounds under ISO 9001 quality management.

catalysischromatographycustom synthesisflow chemistryGC-MShigh pressure/low temperature reactionsHPLCinert gas/organometallic chemistryIRmulti-step organic synthesisphotochemistryprocess developmentroute optimizationroute scoutingScale upSEC

Emery Pharma is a full-service Contract Research Organization (CRO) and GLP/cGMP-compliant contract research laboratory based in Alameda, California. It supports preclinical drug development with analytical and bioanalytical solutions, microbiology and cell biology services, drug and impurity characterization, and general R&D and cGMP/GLP support, delivering customized solutions to fit clients' outsourcing needs.

analytical method developmentbioanalytical assaysbiologics characterizationELISA and MSD immunoassaysGC-MSGLP/cGMP compliancehigh-resolution mass spectrometryHPLC/UPLCLC-MSLC-MS/MSmetabolomicsmethod transfermethod validationmicrobiology testingproteomicsstability testing

GO Composites develops custom towpreg materials and provides composite product and process development and consulting support for aerospace, defense, and industrial applications. The company offers proprietary and custom-formulated resin and adhesive systems, tooling and mandrel development, filament winding, composite materials testing and analysis, failure analysis, and technical consulting from concept to full production.

acoustic emissionscalorimetryfilament windinghigh-speed videographyhydroburst testingILSS testingimpact testingin-plane shear testingmandrel design and developmentmechanical testingnon-destructive testingresin formulationrheologytowpreg developmentultrasonic inspectionwet-winding

GoldenBiotech is an early-stage startup biotech R&D company focusing on novel tailor-made polymeric drug delivery systems, counter-ion complexes, fabrication methods, biomaterials, and specially adjusted formulations to treat serious diseases. It also provides consulting services through The Right Idea – Formulation and Delivery in Biopharma and Biomaterials, LLC. The team has over 30 years of experience in polymeric drug delivery, protein/peptide formulation, combination product/device delivery, and polymeric biomaterials.

3D printing/additive manufacturingcombination product/device deliveryFTIR with ATRin vitro releasein vivo PKLC/MS with UV/Vis detectionmicroparticle fabricationorganic and polymer synthesispolymeric drug deliveryprotein/peptide formulation designrheometrySEC/GPCsterile manufacturingUV/Vis

IRBM is a preclinical drug discovery organization based in Rome, Italy, conducting small molecule, peptide and antibody programs from target validation through to a preclinical candidate, either as a full integrated program or as a single capability for clients. Its scientists have contributed to three approved drugs and delivered more than thirty preclinical candidates to partners.

ADMEantibody phage displayassay developmentBioinformaticsbiophysical characterizationcompound managementcomputational chemistryDMPKfunctional genomicshigh-content screeninghigh throughput screeningin vivo pharmacologymedicinal chemistrymRNA displaypeptide chemistrypeptide phage displayprotein productionstructural biologysynthetic chemistry

Key Organics Limited is a provider of chemistry services, analytical services and BIONET products to the global life science industries, including pharmaceutical, agrochemical and biotechnology sectors. The company offers over 344,000 products, with over 90% in stock, and provides custom synthesis, process development and scale-up, targeted protein degradation, fragment services, compound procurement, consultancy and analytical services.

asymmetric synthesiscarbonylationscustom synthesisGC method developmentheterocyclic chemistryhigh pressure reactionsHPLChydrogenationsmicrowave synthesisparallel synthesisprocess developmentpro-drug synthesisScale upstable labelled compoundssynthetic organic chemistry